America's 10 Highest-Paid CEOs of 2011 (and How They Earned It)
The Richest Woman in the World: How Gina Rinehart Earns her Billions
Check your medicine cabinet for the following medicines for infants included in today's voluntary recall from Johnson & Johnson's (NYSE: JNJ) McNeil-PPC:
- Concentrated Infants' Tylenol Drops plus Cold
- Concentrated Infants' Tylenol Drops plus Cold & Cough
- Pediacare Infant Drops Decongestant
- Pediacare Infant Drops Decongestant & Cough
- Pediacare Infant Dropper Decongestant
- Pediacare Infant Dropper Long-acting Cough
- Pediacare Infant Dropper Decongestant & Cough
The recall does not include similar medicines for children two or older, or single-ingredient pain relievers and fever reducers for infants. The company has not yet divulged the scope or dollar value of this recall.
The company is cooperating with the Consumer Healthcare Products Association in a recommendation to the FDA to prominently label all such products in the future with the warning 'Do not use in children under two years of age."
The two brands included in the recall came to Johnson & Johnson in its purchase of Pfizer's (NYSE: PFE) Consumer Healthcare business late last year.
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
